Finch Therapeutics Group, Inc. - FNCH
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2024
· Q4 2023
Value (USD)
Total reported value ($000)
$259K
QoQ value delta ($000)
-$144K
(-35.73%)
Implied price effect (QoQ)
-27.53%
Shares
Total shares
99,743
QoQ shares delta
-12,732
(-11.32%)
Total shares held by funds (by quarter)
Market chart (FNCH)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2024)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 155 | 59,028 | 0.0% |
| VANGUARD GROUP INC | 94 | 36,252 | 0.0% |
| Tower Research Capital LLC (TRC) | 10 | 4,163 | 0.0% |
| WELLS FARGO & COMPANY/MN | 0 | 7 | 0.0% |
| MORGAN STANLEY | 0 | 156 | 0.0% |
| ROYAL BANK OF CANADA | 0 | 27 | 0.0% |
| UBS Group AG | 0 | 110 | 0.0% |